IQGYAEMXOIUPSE-NLKHACGTSA-N
C26H26ClF3N4O5 — CID 58685711
Data last refreshed: (MolForge compound catalog, from PubChem)
About IQGYAEMXOIUPSE-NLKHACGTSA-N
IQGYAEMXOIUPSE-NLKHACGTSA-N (PubChem CID 58685711) has the molecular formula C26H26ClF3N4O5 and a molecular weight of 566.96 g/mol. Its IUPAC name is 3-chloro-N-[(1S)-3-[[(2R)-3-methyl-1-[(3R,4S)-4-methyl-2,5-dioxopyrrolidin-3-yl]-1-oxobutan-2-yl]amino]-3-oxo-1-phenylpropyl]-5-(trifluoromethyl)pyridine-2-carboxamide.
Molecular Properties
| Compound Name | IQGYAEMXOIUPSE-NLKHACGTSA-N |
|---|---|
| PubChem CID | 58685711 |
| Molecular Formula | C26H26ClF3N4O5 |
| Molecular Weight | 566.96 g/mol |
| Exact Mass | 566.15 |
| IUPAC Name | 3-chloro-N-[(1S)-3-[[(2R)-3-methyl-1-[(3R,4S)-4-methyl-2,5-dioxopyrrolidin-3-yl]-1-oxobutan-2-yl]amino]-3-oxo-1-phenylpropyl]-5-(trifluoromethyl)pyridine-2-carboxamide |
| SMILES | CC(C)[C@@H](NC(=O)C[C@H](NC(=O)c1ncc(C(F)(F)F)cc1Cl)c1ccccc1)C(=O)[C@@H]1C(=O)NC(=O)[C@H]1C |
| InChI | InChI=1S/C26H26ClF3N4O5/c1-12(2)20(22(36)19-13(3)23(37)34-24(19)38)33-18(35)10-17(14-7-5-4-6-8-14)32-25(39)21-16(27)9-15(11-31-21)26(28,29)30/h4-9,11-13,17,19-20H,10H2,1-3H3,(H,32,39)(H,33,35)(H,34,37,38)/t13-,17-,19+,20+/m0/s1 |
| InChIKey | IQGYAEMXOIUPSE-NLKHACGTSA-N |
| XLogP | 3.23 |
| TPSA | 134.33 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 566.96 |
| LogP ≤ 5 | 3.23 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58685711 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.